Apolipoprotein ε4 Is Associated with Lower Brain Volume in Cognitively Normal Chinese but Not White Older Adults

Studying ethnically diverse groups is important for furthering our understanding of biological mechanisms of disease that may vary across human populations. The ε4 allele of apolipoprotein E (APOE ε4) is a well-established risk factor for Alzheimer’s disease (AD), and may confer anatomic and functional effects years before clinical signs of cognitive decline are observed. The allele frequency of APOE ε4 varies both across and within populations, and the size of the effect it confers for dementia risk may be affected by other factors. Our objective was to investigate the role APOE ε4 plays in moderating brain volume in cognitively normal Chinese older adults, compared to older white Americans. We hypothesized that carrying APOE ε4 would be associated with reduced brain volume and that the magnitude of this effect would be different between ethnic groups. We performed whole brain analysis of structural MRIs from Chinese living in America (n = 41) and Shanghai (n = 30) and compared them to white Americans (n = 71). We found a significant interaction effect of carrying APOE ε4 and being Chinese. The APOE ε4xChinese interaction was associated with lower volume in bilateral cuneus and left middle frontal gyrus (Puncorrected<0.001), with suggestive findings in right entorhinal cortex and left hippocampus (Puncorrected<0.01), all regions that are associated with neurodegeneration in AD. After correction for multiple testing, the left cuneus remained significantly associated with the interaction effect (PFWE = 0.05). Our study suggests there is a differential effect of APOE ε4 on brain volume in Chinese versus white cognitively normal elderly adults. This represents a novel finding that, if verified in larger studies, has implications for how biological, environmental and/or lifestyle factors may modify APOE ε4 effects on the brain in diverse populations.

[1]  Edwin K Silverman,et al.  Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma. , 2004, American journal of respiratory and critical care medicine.

[2]  R. Katzman.,et al.  Cross‐national interrater agreement on the clinical diagnostic criteria for dementia , 1994, Neurology.

[3]  Sudha Seshadri,et al.  Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.

[4]  K. Hawkins,et al.  The effects of apolipoprotein E on non-impaired cognitive functioning: A meta-analysis , 2011, Neurobiology of Aging.

[5]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[6]  G. Alexander,et al.  Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. , 2009, The New England journal of medicine.

[7]  Cathy J. Price,et al.  Neuroanatomical markers of speaking Chinese , 2009, Human brain mapping.

[8]  S Lehéricy,et al.  VBM anticipates the rate of progression of Alzheimer disease , 2008, Neurology.

[9]  Stephen M. Rao,et al.  Human Brain Language Areas Identified by Functional Magnetic Resonance Imaging , 1997, The Journal of Neuroscience.

[10]  Caroline Hayward,et al.  Ageing: Cognitive change and the APOE ɛ4 allele , 2002, Nature.

[11]  Howard J. Rosen,et al.  Distinctive Neuropsychological Patterns in Frontotemporal Dementia, Semantic Dementia, And Alzheimer Disease , 2003, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[12]  Ian J. Deary,et al.  Cognitive change and the APOE epsilon 4 allele. , 2002 .

[13]  Christopher A. Hostage,et al.  Dissecting the Gene Dose-Effects of the APOE ε4 and ε2 Alleles on Hippocampal Volumes in Aging and Alzheimer’s Disease , 2013, PloS one.

[14]  Evan Fletcher,et al.  Fully-Automated White Matter Hyperintensity Detection with Anatomical Prior Knowledge and without FLAIR , 2009, IPMI.

[15]  Sterling C. Johnson,et al.  A Journal of Neurology , 2005 .

[16]  Deanna Greenstein,et al.  Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study , 2007, The Lancet Neurology.

[17]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[18]  E. Perez-stable,et al.  Frequency of Dementia Etiologies in Four Ethnic Groups , 2006, Dementia and Geriatric Cognitive Disorders.

[19]  B. Miller,et al.  The neural basis of surface dyslexia in semantic dementia. , 2009, Brain : a journal of neurology.

[20]  Qian Wang,et al.  Association between Apolipoprotein E ε4 and Longitudinal Cognitive Decline: Nested Case-Control Study among Chinese Community-Dwelling Elders , 2011, Neuropsychobiology.

[21]  G. Alexander,et al.  Correlating cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre-mild cognitive impairment. , 2008, Archives of neurology.

[22]  K. Amunts,et al.  Localized morphological brain differences between English-speaking Caucasians and Chinese-speaking Asians: new evidence of anatomical plasticity , 2003, Neuroreport.

[23]  H. Arrighi,et al.  Apolipoprotein E ε4 Prevalence in Alzheimer’s Disease Patients Varies across Global Populations: A Systematic Literature Review and Meta-Analysis , 2010, Dementia and Geriatric Cognitive Disorders.

[24]  P. Matthews,et al.  Distinct patterns of brain activity in young carriers of the APOE e4 allele , 2009, NeuroImage.

[25]  A. Chesson.  Aphasia following a right thalamic hemorrhage , 1983, Brain and Language.

[26]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Andrew J. Saykin,et al.  Regional brain atrophy in cognitively intact adults with a single APOE ε4 allele , 2006, Neurology.

[28]  Giovanni B. Frisoni,et al.  Regional atrophy of transcallosal prefrontal connections in cognitively normal APOE ϵ4 carriers , 2009, Journal of magnetic resonance imaging : JMRI.

[29]  J. Morris.  The Clinical Dementia Rating (CDR) , 1993, Neurology.

[30]  C. Hong,et al.  epsilon 4 Allele of apolipoprotein E increases risk of Alzheimer's disease in a Chinese population , 1996, Neurology.

[31]  W. Chan,et al.  Apolipoprotein E Polymorphism and Age at Onset of Alzheimer’s Disease in a Quadriethnic Sample , 2011, Dementia and Geriatric Cognitive Disorders.

[32]  Helen J. Chenery,et al.  Language disorders in dementia of the Alzheimer type , 1987, Brain and Language.

[33]  G J Tsongalis,et al.  Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele. , 2006, Neurology.

[34]  Y. Stern,et al.  Imaging studies and APOE genotype in persons at risk for Alzheimer’s disease , 1996, Current psychiatry reports.

[35]  Yuncheng Wu,et al.  A clinical memory battery for screening for amnestic mild cognitive impairment in an elderly chinese population , 2011, Journal of Clinical Neuroscience.

[36]  N. Risch,et al.  Genetic admixture and asthma‐related phenotypes in Mexican American and Puerto Rican asthmatics , 2005, Genetic epidemiology.

[37]  F. Dick,et al.  Voxel-based lesion–symptom mapping , 2003, Nature Neuroscience.

[38]  Jing He,et al.  Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phase. , 2010, Archives of neurology.

[39]  G. Alexander,et al.  Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[40]  C. Hong,et al.  APOE ϵ4 increases the risk of progression from amnestic mild cognitive impairment to Alzheimer's disease among ethnic Chinese in Taiwan , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[41]  S. Gauthier,et al.  Apolipoprotein E polymorphism and Alzheimer's disease , 1993, The Lancet.

[42]  R. Corbo,et al.  Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele? , 1999, Annals of human genetics.

[43]  G. Frisoni,et al.  Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment , 2007, Journal of Neurology.

[44]  Tianzi Jiang,et al.  Cortical thickness is associated with different apolipoprotein E genotypes in healthy elderly adults , 2010, Neuroscience Letters.

[45]  E. Silverman,et al.  Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. , 2005, American journal of respiratory and critical care medicine.

[46]  C. Hong,et al.  The allele interaction between apolipoprotein ɛ2 and ɛ4 in Taiwanese Alzheimer's disease patients , 2005 .

[47]  S. Gabriel,et al.  EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy , 2004, Science.

[48]  W. Tsai,et al.  Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. , 1996, American journal of human genetics.

[49]  J. Buxbaum,et al.  Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. , 1997, The New England journal of medicine.

[50]  Sachin Dixit,et al.  APOE4 Allele Disrupts Resting State fMRI Connectivity in the Absence of Amyloid Plaques or Decreased CSF Aβ42 , 2010, The Journal of Neuroscience.

[51]  D. Holtzman,et al.  Apolipoprotein E in Alzheimer's disease and other neurological disorders , 2011, The Lancet Neurology.

[52]  N. Venketasubramanian,et al.  Interethnic Differences in Dementia Epidemiology: Global and Asia-Pacific Perspectives , 2011, Dementia and Geriatric Cognitive Disorders.

[53]  Michael Weiner,et al.  Neuroanatomical correlates of cognitive self-appraisal in neurodegenerative disease , 2010, NeuroImage.

[54]  J. Lirng,et al.  Prediction of Alzheimer's disease in mild cognitive impairment: A prospective study in Taiwan , 2006, Neurobiology of Aging.

[55]  H. Braak,et al.  High Frequency of Apolipoprotein E ϵ4 Allele in Young Individuals with Very Mild Alzheimer's Disease-Related Neurofibrillary Changes , 1998, Experimental Neurology.

[56]  B. Miller,et al.  Heightened emotional contagion in mild cognitive impairment and Alzheimer’s disease is associated with temporal lobe degeneration , 2013, Proceedings of the National Academy of Sciences.

[57]  Francesca M. Filbey,et al.  Functional magnetic resonance imaging and magnetoencephalography differences associated with APOEϵ4 in young healthy adults , 2006, Neuroreport.

[58]  M. Prince,et al.  Dementia diagnosis in developing countries: a cross-cultural validation study , 2003, The Lancet.

[59]  E. Oguni,et al.  Dose‐dependent association of apolipoprotein e allele ε4 with late‐onset, sporadic Alzheimer's disease , 1994 .

[60]  Chin‐Chang Huang,et al.  Association of Apolipoproteins E4 and C1 With Onset Age and Memory: A Study of Sporadic Alzheimer Disease in Taiwan , 2010, Journal of geriatric psychiatry and neurology.

[61]  Xue Hua,et al.  Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study. , 2014, JAMA neurology.

[62]  Peter Boesiger,et al.  Better Memory and Neural Efficiency in Young Apolipoprotein E ε4 Carriers , 2007 .

[63]  H. Rosen,et al.  Recruitment of Chinese American elders into dementia research: the UCSF ADRC experience. , 2011, The Gerontologist.